GLS and breast carcinoma: Similarly, the overexpression of SIRT5 in breast cancer protects the mitochondrial enzyme glutaminase (GLS) from ubiquitin-mediated degradation through SIRT5 dependent-desuccinylation of lysine164 residue, which stabilizes GLS [86].